Literature DB >> 31732846

Role of the PI3K and Hippo pathways in follicle activation after grafting of human ovarian tissue.

Rossella Masciangelo1, Camille Hossay1, Maria Costanza Chiti1, Diego Daniel Manavella1, Christiani Andrade Amorim1, Jacques Donnez2, Marie-Madeleine Dolmans3,4.   

Abstract

PURPOSE: Our aim was to elucidate the mechanisms involved in follicle activation of the ovarian reserve after human ovarian tissue transplantation, with specific focus on the role of the effectors of the PI3K (mTOR and FOXO1) and Hippo (YAP) signaling pathways and whether they are somehow altered.
METHODS: Frozen-thawed ovarian tissue was collected from six women (age 25-35 years) undergoing surgery for non-ovarian pathologies and divided into 4 fragments in each case: one for non-grafted controls and three for grafting to immunodeficient mice for 3, 7 and 21 days. The tissue was processed for hematoxylin and eosin staining, immunohistochemistry and immunofluorescence at different timepoints before and after grafting. Activation of the PI3K and Hippo signaling pathways was investigated by analysis of mTOR phosphorylation, FOXO1 cytoplasmic localization and YAP nuclear localization.
RESULTS: No change in mTOR levels was observed in primordial follicles post-transplantation, but a significant upturn was recorded in growing follicles compared with primordial follicles, irrespective of grafting time. A higher percentage of primordial follicles was also found with FOXO1 in the cytoplasm after 3 days of transplantation than in non-grafted controls. Finally, a greater proportion of primordial follicles was detected with YAP in the nucleus at all timepoints after grafting.
CONCLUSIONS: This study supports the hypothesis that follicle activation may occur as an early event after transplantation, with follicle growth and death both contributing to the burnout phenomenon. This is the first time that the effectors of the PI3K and Hippo pathways have been investigated in grafted human ovarian tissue and their role in burnout documented.

Entities:  

Keywords:  Burnout effect; Follicle activation; Hippo pathway; Ovarian tissue transplantation; PI3K pathway

Mesh:

Substances:

Year:  2019        PMID: 31732846      PMCID: PMC7000614          DOI: 10.1007/s10815-019-01628-1

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  39 in total

Review 1.  Cellular and molecular regulation of the activation of mammalian primordial follicles: somatic cells initiate follicle activation in adulthood.

Authors:  Hua Zhang; Kui Liu
Journal:  Hum Reprod Update       Date:  2015-07-30       Impact factor: 15.610

2.  Activation of dormant ovarian follicles to generate mature eggs.

Authors:  Jing Li; Kazuhiro Kawamura; Yuan Cheng; Shuang Liu; Cynthia Klein; Shu Liu; En-Kui Duan; Aaron J W Hsueh
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

Review 3.  Fertility preservation for young patients with cancer: who is at risk and what can be offered?

Authors:  W Hamish B Wallace; Richard A Anderson; D Stewart Irvine
Journal:  Lancet Oncol       Date:  2005-04       Impact factor: 41.316

4.  Adipose tissue-derived stem cells in a fibrin implant enhance neovascularization in a peritoneal grafting site: a potential way to improve ovarian tissue transplantation.

Authors:  D D Manavella; L Cacciottola; C M Desmet; B F Jordan; J Donnez; C A Amorim; M M Dolmans
Journal:  Hum Reprod       Date:  2018-02-01       Impact factor: 6.918

Review 5.  Fertility Preservation in Women.

Authors:  Jacques Donnez; Marie-Madeleine Dolmans
Journal:  N Engl J Med       Date:  2017-10-26       Impact factor: 91.245

Review 6.  Hippo signaling in organ size control.

Authors:  Duojia Pan
Journal:  Genes Dev       Date:  2007-04-15       Impact factor: 11.361

7.  Disruption of Tsc2 in oocytes leads to overactivation of the entire pool of primordial follicles.

Authors:  Deepak Adhikari; Gilian Flohr; Nagaraju Gorre; Yan Shen; Hairu Yang; Eva Lundin; Zijian Lan; Michael J Gambello; Kui Liu
Journal:  Mol Hum Reprod       Date:  2009-10-20       Impact factor: 4.025

Review 8.  Defining the role of mTOR in cancer.

Authors:  David A Guertin; David M Sabatini
Journal:  Cancer Cell       Date:  2007-07       Impact factor: 31.743

9.  Two-step transplantation with adipose tissue-derived stem cells increases follicle survival by enhancing vascularization in xenografted frozen-thawed human ovarian tissue.

Authors:  D D Manavella; L Cacciottola; S Pommé; C M Desmet; B F Jordan; J Donnez; C A Amorim; M M Dolmans
Journal:  Hum Reprod       Date:  2018-06-01       Impact factor: 6.918

10.  In vitro Activation Prior to Transplantation of Human Ovarian Tissue: Is It Truly Effective?

Authors:  Marie-Madeleine Dolmans; Florence Cordier; Christiani A Amorim; Jacques Donnez; Catherine Vander Linden
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-02       Impact factor: 5.555

View more
  12 in total

1.  The effect of mTOR activation and PTEN inhibition on human primordial follicle activation in ovarian tissue culture.

Authors:  Zeinab Ghezelayagh; Naeimeh Sadat Abtahi; Mojtaba Rezazadeh Valojerdi; Bita Ebrahimi
Journal:  J Assist Reprod Genet       Date:  2022-07-11       Impact factor: 3.357

Review 2.  The process of ovarian aging: it is not just about oocytes and granulosa cells.

Authors:  Antonella Camaioni; Maria Assunta Ucci; Luisa Campagnolo; Massimo De Felici; Francesca Gioia Klinger
Journal:  J Assist Reprod Genet       Date:  2022-04       Impact factor: 3.357

3.  In-vitro fragmentation of ovarian tissue activates primordial follicles through the Hippo pathway.

Authors:  C De Roo; S Lierman; K Tilleman; P De Sutter
Journal:  Hum Reprod Open       Date:  2020-11-16

4.  Altered expression of activator proteins that control follicle reserve after ovarian tissue cryopreservation/transplantation and primordial follicle loss prevention by rapamycin.

Authors:  Soner Celik; Sinan Ozkavukcu; Ciler Celik-Ozenci
Journal:  J Assist Reprod Genet       Date:  2020-07-10       Impact factor: 3.412

5.  Adipose tissue-derived stem cells protect the primordial follicle pool from both direct follicle death and abnormal activation after ovarian tissue transplantation.

Authors:  Luciana Cacciottola; Guillaume E Courtoy; Thu Y T Nguyen; Camille Hossay; Jacques Donnez; Marie-Madeleine Dolmans
Journal:  J Assist Reprod Genet       Date:  2020-11-12       Impact factor: 3.412

6.  Long-Term Advantages of Ovarian Reserve Maintenance and Follicle Development Using Adipose Tissue-Derived Stem Cells in Ovarian Tissue Transplantation.

Authors:  Luciana Cacciottola; Thu Y T Nguyen; Maria C Chiti; Alessandra Camboni; Christiani A Amorim; Jacques Donnez; Marie-Madeleine Dolmans
Journal:  J Clin Med       Date:  2020-09-15       Impact factor: 4.241

7.  Evaluation of an alternative heterotopic transplantation model for ovarian tissue to test pharmaceuticals improvements for fertility restoration.

Authors:  Carmen Terren; Jules Bindels; Michelle Nisolle; Agnès Noël; Carine Munaut
Journal:  Reprod Biol Endocrinol       Date:  2022-02-19       Impact factor: 5.211

8.  Drug-free in vitro activation combined with 3D-bioprinted adipose-derived stem cells restores ovarian function of rats with premature ovarian insufficiency.

Authors:  Qian Li; Jiahua Zheng; Zhongkang Li; Yanlai Xiao; Mingle Zhang; Wenxin Shi; He Gao; Xianghua Huang; Jingkun Zhang
Journal:  Stem Cell Res Ther       Date:  2022-07-26       Impact factor: 8.079

9.  Lysophosphatidic Acid Accelerates Bovine In Vitro-Produced Blastocyst Formation through the Hippo/YAP Pathway.

Authors:  Bo Yu; Helena T A van Tol; Christine H Y Oei; Tom A E Stout; Bernard A J Roelen
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

10.  Pharmacological inhibition of the PI3K/PTEN/Akt and mTOR signalling pathways limits follicle activation induced by ovarian cryopreservation and in vitro culture.

Authors:  Carmen Terren; Michelle Nisolle; Carine Munaut
Journal:  J Ovarian Res       Date:  2021-07-19       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.